Revolution Medicines Inc

General ticker "RVMD" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $8.2B

Revolution Medicines Inc follows the US Stock Market performance with the rate: 60.4%.

Estimated limits based on current volatility of 1.4%: low 43.33$, high 44.57$

Factors to consider:

  • Current price 21.9% above estimated high
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [17.93$, 36.05$]
  • 2024-12-30 to 2025-12-30 estimated range: [15.14$, 31.43$]

Financial Metrics affecting the RVMD estimates:

  • Negative: Non-GAAP EPS, $ of -3.77 <= 0.10
  • Negative: Operating profit margin, % of -97.68 <= 1.03
  • Negative: Operating cash flow per share per price, % of -11.06 <= 2.35
  • Negative: negative Net income

Similar symbols

Short-term RVMD quotes

Long-term RVMD plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $29.39MM $35.38MM $11.58MM
Operating Expenses $217.40MM $293.66MM $498.76MM
Operating Income $-188.01MM $-258.28MM $-487.19MM
Non-Operating Income $0.92MM $9.15MM $47.29MM
Interest Expense $0.01MM $0.00MM $0.30MM
R&D Expense $186.95MM $253.07MM $423.14MM
Income(Loss) $-187.09MM $-249.12MM $-439.89MM
Taxes $0.00MM $-0.42MM $-3.52MM
Profit(Loss) $-187.09MM $-248.71MM $-436.37MM
Stockholders Equity $602.57MM $685.19MM $1,826.19MM
Inventory $12.72MM $0.00MM $0.00MM
Assets $737.99MM $811.93MM $2,061.70MM
Operating Cash Flow $-147.18MM $-224.40MM $-350.57MM
Capital expenditure $6.53MM $10.82MM $7.73MM
Investing Cash Flow $-142.12MM $-24.12MM $-342.60MM
Financing Cash Flow $294.18MM $301.43MM $1,229.20MM
Earnings Per Share* $-2.47 $-3.08 $-3.86

* EPS are Split Adjusted, recent splits may be reflected with a delay.